BioHorizons Camlog launches Striate+

Search Dental Tribune

BioHorizons Camlog launches Striate+ collagen membrane

Striate+ leverages the manufacturing process, referred to as Scaffold Matrix Regenerative Therapy, to remove immunogens from porcine collagen, ensuring biocompatibility and integration, and promotes bone formation with its bilayer structure. (Image: BioHorizons Camlog)

Fri. 16. February 2024


BASEL, Switzerland: BioHorizons Camlog has announced the launch of Striate+, an innovative collagen membrane developed by Orthocell for advanced bone and tissue regeneration. Both companies have entered into a global distribution and manufacturing agreement for Striate+. The product strengthens BioHorizons Camlog’s position as a global provider of regenerative solutions for implant dentistry and covers the needs of a large portion of clinicians looking to improve the outcomes of their surgical procedures.

The combination of superior handling, optimal durability, osteoconductivity and enhanced clinical outcomes makes Striate+ the membrane of choice for guided bone and tissue regeneration. (Image: BioHorizons Camlog)

Striate+ is manufactured from porcine-derived raw materials, selectively sourced from Australian veterinary-certified animals. The manufacturing process, referred to as Scaffold Matrix Regenerative Therapy, removes immunogenic contaminants and ensures high biocompatibility while preserving the structure of the native collagen. The absence of any chemical modification or cross-linking promotes the integration of Striate+ with the surrounding soft tissue and can help minimise the risk of wound dehiscence. Striate+ is fully resorbed through physiological processes within 26 weeks, eliminating the need for a second surgical intervention to remove the product.

Furthermore, Striate+ exhibits excellent handling and usability. It can be applied without prior hydration and will gently conform and adhere to the defect contours without fixation, yet can be stabilised by suturing and pinning, if needed. A recent comparative study demonstrated that Striate+ had higher mechanical strength than a leading competitor’s product. The membrane absorbs fluids by capillarity but does not swell excessively, facilitating primary closure and making it particularly suitable for patients with a thin periodontal biotype.

Striate+ has a bilayer structure with a rough side and a smooth side. The smooth side comprises densely packed collagen fibres and acts as a barrier to the infiltration of gingival cells while allowing the passage of bioactive molecules. Conversely, the rough side, composed of loosely distributed collagen fibres, provides a scaffold for osteoprogenitor cells to deposit osteoid. This results in active promotion of bone formation and allows for early implant placement.

Striate+ is now exclusively available for ordering through BioHorizons Camlog in Belgium, France, Ireland, Italy, the Netherlands, Portugal, Spain and the UK. For further information about Striate+, please visit

To post a reply please login or register